Topical treatments for scalp psoriasis

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Scalp psoriasis is a prevalent, chronic inflammatory skin condition with high visibility, causing significant psychosocial distress.
• Current topical treatments are often ineffective, inconvenient, and lead to poor patient compliance.
• Existing evidence for topical therapies primarily stems from uncontrolled studies, lacking rigorous evaluation.

Purpose of the Study:

• To critically assess the effectiveness and tolerability of available topical therapies for scalp psoriasis.
• To identify gaps in current treatment strategies, such as the role of keratolytics.
• To provide evidence-based recommendations for selecting scalp psoriasis treatments.

Main Methods:

• Systematic review and critical appraisal of existing literature on topical treatments for scalp psoriasis.
• Analysis of data from controlled trials, where available, and open-label studies.
• Evaluation of treatment formulations, efficacy, tolerability, and adherence factors.

Main Results:

• Topical corticosteroids and vitamin D analogues show some efficacy but require further investigation.
• The role of keratolytics in enhancing the efficacy of other topical agents needs to be addressed in controlled trials.
• Limited high-quality evidence exists for many current treatment regimens.

Conclusions:

• There is an urgent need for well-designed, controlled trials to evaluate existing and novel topical treatments for scalp psoriasis.
• Optimizing treatment selection requires considering factors beyond basic drug efficacy, including adherence and adjunctive therapies.
• Improved therapeutic strategies are needed to enhance patient outcomes and quality of life for individuals with scalp psoriasis.